OncoResponse, Inc — Form D

OncoResponse, Inc of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-06. $6.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Roberto D De PontiDirectorHOUSTON, TX
Carol D GallagherDirectorHOUSTON, TX
Steven D GillisDirectorHOUSTON, TX
Wende D HuttonDirectorHOUSTON, TX
Sean A McCarthyDirectorHOUSTON, TX
John A McKearnDirectorHOUSTON, TX
Clifford J StocksDirectorHOUSTON, TX
Alice J BexonExecutive OfficerHOUSTON, TX
Kamal D PuriExecutive OfficerHOUSTON, TX
Chris D RussellExecutive OfficerHOUSTON, TX
Clifford J StocksExecutive OfficerHOUSTON, TX
Steve GillisDirectorNew York, NY
Steven GillisDirectorSouth San Francisco, CA
Andrew PerlmanDirectorAtlanta, GA
Geeta VemuriDirectorWaltham, MA
TED KOUTOUZISDirectorSANTA CLARA, CA
Wende HuttonDirectorMenlo Park, CA
Clifford StocksDirectorHouston, TX
Clifford StocksExecutive OfficerHouston, TX
Roberto De PontiDirectorPhiladelphia, PA
Roberto A DePontiDirectorNone, N4
Ted A KoutouzisDirectorEvanston, IL
Steven A GillisDirectorChicago, IL
Robert J LechleiderExecutive OfficerSeattle, WA
Wende A HuttonDirectorMenlo Park, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2023-05-12D$40.0M$13.9M
2021-03-31D$60.0M$40.6M
2018-09-06D$40.0M$19.0M
2017-03-23D/A$34.0M$29.5M
2016-05-26D/A$28.2M$19.5M
2015-10-15D$28.2M$16.5M

More